CDISC Standards Webinar Latest Updates and Additions 31 Jan 2013
|
|
- Antony McCoy
- 5 years ago
- Views:
Transcription
1 CDISC Standards Webinar Latest Updates and Additions 31 Jan 2013
2 CDASH-SAE Domains CDISC CDASH SAE Team Update Rhonda Facile, CDISC Gary Walker, Quintiles CDISC
3 Agenda Background Mapping CDASH to E2B New Domains and Variables Timeline to publication Acknowledgements CDISC
4 Background The project started in 2010 Initiative sponsors: Barry Burnstead, Rhonda Facile Initial goal was to identify and describe the E2B fields that are collected at investigational sites. CDASH-E2B team officially formed CDISC
5 CDASH-E2B: Why? Reporting serious adverse events (SAEs) to regulatory bodies in a timely manner during the course of a clinical study is critical for Sponsors. However, in most cases, clinical data is not captured in line with the E2B industry safety standard, leading to a disconnect between clinical and safety databases. CDASH being the first standard applied to clinical data at point of capture needs to take account of all data requirements and destinations. CDISC
6 Our Goals To eliminate duplication of data collection enter data once, use when and where needed To provide the needed (and standardised) metadata that will assist and support drug safety in meeting regulatory reporting requirements CDISC
7 Mapping E2B to CDASH fields E2B R2 vs. CDASH 1.1 CDISC 2013
8 Gap Analysis A total of 235 E2B fields have been identified. 150 fields are not typically collected at site or do not have a CDASH identity 16 fields could/should be known or collected eg, causality assessment, reporter comments, country where the event occurred 85 fields are collected at site 68 fields already have CDASH identity 19 fields need a CDASH identity developed primarily regarding Parent and Death areas CDISC 2013
9 New Domains and Variables New CDASH identities recommended for the 35 identified gap fields Additional 15 identified during the F2F Meeting New SAE CDASH domain recommended SAE Addendum to CDASH being drafted Fields currently excluded from the CDASH-E2B mapping will be reviewed in future versions CDISC 2013
10 CDASH Data Elements DM, CM, MH, etc. CRF Domains data Investigator provides information through a single interface. ( combo form, linked forms, conditional forms) CDASH Data Elements: AE Domain AE CRF Data SAE Domain SAE Form Data All relevant clinical and related information including patient characteristics, therapy details, medical history, clinical course of the event, laboratory evidence and any other information that supports or refutes causality. Research Database Sponsor Safety Database Submit study data in SDTM format to regulators as needed. Report in E2B format to Health Authorities and other recipients in required timeframe
11 Examples of SAE domain data not already collected in CDASH CDASH SAE-specific variables SAERPTRFNM (SAE reporter s family name) ICSRID (Sender s safety case report unique ID) Subject data that could map to SDTM domains AUCDTH (DDORRES when DDTEST= Autopsy determined cause of death ) AUPERF (PROCCUR when PRTERM= Autopsy ) Data for Associated Persons that could map to SDTM domains APDM.AGE (APDM.AGE when DMRELSUB = Father, Biological ) APMH.MHTERM (APMH.MHTERM when MHRELSUM = Father, Biological ) CDISC
12 TENTATIVE TIMELINE TO PUBLICATION Submit to SRC for approval to post for public comment (February) Public review (March) Submit to SRC for approval to publish (April) Testing Initial Consensus Version TLC Review Harmonized Version OK CDISC Internal Review OK Reviewed Version Public Review Released (Production) Version (1.0) comments addressed by team SRC Review (For approval to post for public review) CDISC
13 CDASH-E2B Team Name Region Affiliation Address Gary Walker US Quintiles Barry Burnstead EU Select CRO Lauren Shinaberry EU Business & Decision Life Sciences Sonia Araujo EU Medidata Solutions Sean Neak EU Medidata Solutions Roland Franke EU PRA International Tracy Sanders US Foresight Group Ling Chin, MD, MPH US Consultant, GCP Clinical Trials Monica Mattson US Celgene Shannon Labout US CDISC Rhonda Facile US CDISC CDISC 2013
14 Questions Rhonda Facile Gary Walker CDISC
15 CDISC Online Training Saad Yousef, CDISC 15
16 Online Courses coming soon! Courses split into modules Technical and Therapeutic Area courses will be offered TA courses offered online only Technical courses still offered via public and private training First few modules to be available in early February. 16
17 How to sign up? Each registrant must create account by going to Same discounts available for GOLD (20%) and PLATINUM (40%) members. Discount codes are case sensitive. Each course contains an exam. Certificates available for passing candidates (automatic). 17
18 Advantages/Disadvantages Advantages Take courses from comfort of own office/home Self-paced Automatic certificate after test successfully passed Disadvantages No opportunity for discussion or to ask questions to an instructor Still have option of signing up for public and private courses. Click here for more info. No opportunity to network with others had you registered for public course offering. Click here for public course offering. 18
19 Questions? Please start sending in questions pertaining to CDASH-SAE or CDISC Online Training. 19
20 CDISC Education and Communications Updates Presented by: Saad Yousef, CDISC, Associate of Education and Operations 20
21 Read the Latest CDISC News Join our list Read our monthly e-newsletter See the CDISC home page: for all current events Read our Blogs: Follow us on social media! 21
22 What s New on the CDISC Website Subscribe to RSS Feeds Clear and easy display of the CDISC Standards and Innovations 22
23 What s New on the CDISC Website Rotating Banner at the bottom of the Home page and the Newsletter page to value our Platinum Members
24 Inaugural Asia-Pacific Interchange
25 Interchange Details Asia-Pacific Interchange in Singapore, Feb 2013 Deadline to register is 8 Feb 2013 Sponsorship opportunities available Education courses offered: ADaM, CDASH, Controlled Terminology, and SDTM 25
26 CDISC European Interchange
27 Interchange Details Europe Interchange in Germany, April 2013 Registration is now open Sponsorship opportunities available Education courses offered: ADaM, BRIDG Deep Dive, CDASH, Controlled Terminology, ODM, and SDTM 27
28 Other Public Education Opportunities Morrisville, NC from February 2013 South San Francisco, CA from 5-8 March 2013 St. Louis, MO from May 2013 Cambridge, MA on 17 July 2013 Full schedule and registration at Early registration discounts available for select public training events. Please click on the above link to access event registration details. 28
29 CDISC In-House Education Schedule in-house authorized CDISC education for your company - designed to meet your CDISC education needs. For more information: Visit our website or fill out private education request form found here (form can also be found at above webpage). 29
30 CDISC Authorized Instructors Find out who our instructors are at
31 Upcoming CDISC Webinars Watch for more CDISC Team Updates and other topics in our Webinar Series in the coming months CDISC Webinar schedule published at: Next webinar is scheduled for 7 March Visit the CDISC website (link above) for info on next year s webinars. 31
32 Get Involved! Become a CDISC Member Participate in Public Reviews Attend the Interchanges and authorized training Be a key collaborator Adopt the standards ask partners to do so Spread the word Volunteer For more information about CDISC please visit our website: 32
33 Any more questions? Thank you for attending this webinar. CDISC s vision is to: Inform Patient Care & Safety Through Higher Quality Medical Research 33
PROGRAM INTERCHANGE Japan
A collaborative event to share progress, implementation experiences, and strategic ideas on worldwide data interchange standards for medical research. PROGRAM INTERCHANGE Japan 20-23 July 2010 Toshi Center
More informationPDUFA IV Information Technology Plan. Armando Oliva, M.D. Deputy Director for Bioinformatics Office of Critical Path Programs FDA
PDUFA IV Information Technology Plan Armando Oliva, M.D. Deputy Director for Bioinformatics Office of Critical Path Programs FDA Outline What is the PDUFA IV IT Plan? What does it say? How can CDISC and
More informationSite-Less CRO Model and esource: Framework for Action
Site-Less CRO Model and esource: Framework for Action Joe Martinez, RPh, PDE, PPC Princeton, NJ In-home and site-less clinical trials: changing the landscape How to test drugs, devices and procedures better
More informationBeijing esubmission Packages
Single Day Event Beijing esubmission Packages 8th July 2016 Park Plaza Beijing Science Park Beijing 2016 PhUSE Single Day Event 1 Your guide to the day Introduction Agenda Time Title and Speaker 09:00
More informationNew European Union Clinical Trial Regulations
New European Union Clinical Trial Regulations Incorporate Monitoring and Safety Reporting Techniques into U.S. and EU Clinical Trial SOPs Anita K. Murthy Deputy Director, Global Regulatory Affairs Bayer
More informationIntroduction to China CDISC Coordinating Committee (C3C) February 2014
Introduction to China CDISC Coordinating Committee (C3C) February 2014 Outline Regulatory history of study data in China CDISC application and history in China China CDISC coordinating committee (C3C)
More informationEvaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare
Notification number: 0427-1 April 27, 2015 To: Prefectural Health Department (Bureau) Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Notification
More informationClinical Research Professionals
Training & Resources for Clinical Research Professionals Course & Publications Catalog January July 2016 In-Person and Web-Based Training Courses, Customized Training, elearning and Publications for Clinical
More informationCDISC Asia-Pacific/Japan Interchange CDISC Standards: Transcending Geographic Lines for the Betterment of Clinical Research
CDISC Asia-Pacific/Japan Interchange CDISC Standards: Transcending Geographic Lines for the Betterment of Clinical Research 28 July - 01 August 2014 AP Tokyo Yaesu-Dori KPP Yaesu Building Tokyo, Japan
More informationWhy do we need an addendum to ICH E6?
Addendum to ICH E6 Hideaki Ui, Ph.D. Inspection Director Office of Non-clinical and Clinical Compliance Pharmaceuticals and Medical Devices Agency, Japan Disclaimer The views and opinions expressed in
More information2014 CDISC International Interchange Conference Program
2014 CDISC International Interchange Conference Program Embracing a Changing Landscape Standards to Connect Research and Patient Care B e t h e s d a N o r t h M a r r i o t t H o t e l a n d C o n f e
More informationNow We are Getting to the Hard Parts: An Analysis Files Perspective
Now We are Getting to the Hard Parts: An Analysis Files Perspective Steve Wilson Director, CDER/OTS/OB/DBIII 2010 CDISC Interchange Renaissance Hotel, Baltimore, MD November 3-4, 2010 Disclaimer Views
More informationTargeted technology and data management solutions for observational studies
Targeted technology and data management solutions for observational studies August 18th 2016 Zia Haque Arshad Mohammed Copyright 2016 Quintiles Your Presenters Zia Haque Senior Director of Data Management,
More informationJapanese submission/approval processes from programming perspective Ryan Hara, Novartis Pharma AG, Basel, Switzerland
PharmaSUG 2015 - Paper SS02 Japanese submission/approval processes from programming perspective Ryan Hara, Novartis Pharma AG, Basel, Switzerland The opinions expressed in this paper and on the following
More informationEV Reporting process for users: Creating and sending ICSRs using EVWEB part II
EV Reporting process for users: Creating and sending ICSRs using EVWEB part II Training Module EV-M3e An agency of the European Union Content Summary Introduction Nullifications and Amendments Creating
More informationCommission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo
Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics 30.1.2017 Oslo 3.2.2017 O. Konttinen 1 Background Based on directive 2001/20/EC of the clinical trials on medicinal
More informationGeneral Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility
General Administration GA 102.01 STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility Approval: Nancy Paris, MS, FACHE President and CEO (17 July 2014) (Signature and
More informationIntroduction To Medpace & Clinical Research Overview
Introduction To Medpace & Clinical Research Overview Medpace Overview o o o o o We are a Contract Research Organization (CRO) Work closely with biotech, pharma, and device companies Full Service Model
More informationKeele Clinical Trials Unit
Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title Safety Reporting and Pharmacovigilance SOP Index Number SOP 20 Version 4.0 Approval Date 31-Jan-2017 Effective Date 14-Feb-2017
More informationStudy Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)
Replaces previous version 203.01: 01 July 2014 Study Start-Up SS 203.01 STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV) Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature
More informationPaper PO 53. Reporting of treatment emergent adverse events based on pooled data Analysis or Country Specific Submissions: A case study
Paper PO 53 Reporting of treatment emergent adverse events based on pooled data Analysis or Country Specific Submissions: A case study Sheetal Shiralkar- Independent Consultant. Plainsboro-NJ Often sponsor
More informationSTEM Academy Project Based Learning
STEM Academy Project Based Learning LIGHT Awards Program 2015 Laura Beaudrow 1234 Main Street San Francisco, CA 94105 info@lightawards.org Printed On: 7 October 2014 LIGHT Awards Program 2015 1 Application
More informationTORA User Guide. How to Submit an Application on TORA for Institutional Approval
TORA User Guide How to Submit an Application on TORA for Institutional Approval Contents User Guide Objectives... 1 Logging in to TORA... 1 Menu Pages View... 3 Completing the Form... 3 Tab 1: Project
More information1. Introduction, purpose of this Standard Operating Procedure (SOP)
Details Document Type Document name Ref # Version Effective from Review date Owner Prepared by Reviewed by Approved by Superseded documents Relevant regulations/legislation/guidelines/reference Standard
More information1. Introduction, purpose of this Standard Operating Procedure (SOP)
SOP-CTN-001- Clinical Trial Network - General Organisation and Principles European Society of Anaesthesiology Details Document Type Document name Ref # Version Effective from Review date Owner Prepared
More informationMassHealth Provider Billing and Services Updates & Upcoming Initiatives. Massachusetts Health Care Training Forum July 2011
MassHealth Provider Billing and Services Updates & Upcoming Initiatives Massachusetts Health Care Training Forum July 2011 Agenda I. MassHealth Updates/Resources & Upcoming MassHealth Initiatives II. Paper
More informationGlobal Village / Stand Submission form
WE SHOWCASE The European Development Days 2018 5-6 June 2018 Brussels, Belgium eudevdays.eu Global Village / Stand Submission form International Cooperation and Development STEP 1 GENERAL The EDD Global
More informationSponsor and Exhibitor Prospectus
Sponsor and Ehibitor Prospectus March 14-16, 2017 Marriott Shanghai City Center Shanghai, China MBA Career Services & Employer Alliance Setting the Standard. Connecting the Industry. Thank you for your
More informationStudy Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting
Study Management SM 306.00 STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval: Frederick M. Schnell, MD,
More informationS t r e n g t h t h r o u g h C o l l a b o r a t i o n
THE INTERCHANGE SCHEDULE S t r e n g t h t h r o u g h C o l l a b o r a t i o n MONDAY 4 MAY 2015 09:00 17:30 FDA Reviewer Session 09:00 12:30 Controlled Terminology Course 09:00 17:30 CDASH Implementation
More informationAddendum to ICH E6 (R2)
Addendum to ICH E6 (R2) Stephanie Shapley (US FDA) - Rapporteur Dr. Fergus Sweeney (EMA) - Regulatory Chair Date: December 15, 2015 International Council for Harmonisation of Technical Requirements for
More informationAnnex 1 EXHIBITION & SPONSORSHIP PLANNER. 17 May 2018 Crowne Plaza Dublin Blanchardstown Dublin Ireland. Revision of the EU GMP Guideline
PDA Europe Workshop, Exhibition, Education The Parenteral Drug Association presents: Annex 1 Revision of the EU GMP Guideline EXHIBITION & SPONSORSHIP PLANNER pda.org/eu/annex1_dublin 17 May 2018 Crowne
More informationFeedback from our EARMA 2015 workshop: Research Funding Identification, Engagement and Dissemination Strategies
Idox Feedback from our EARMA 2015 workshop: Research Funding Identification, Engagement and Dissemination Strategies June July 2015 rc.research@idoxgroup.com Contents Introduction... 2 The University of
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM 003 SOP category: Trial Management Version number: 03 Version date:
More informationCare Partners Monthly Webinar #3
Care Partners Monthly Webinar #3 August 17 th & 19 th, 2015 Theresa Hoeft, PhD Ashley Heald, MA 2 Agenda Patient Consents Psychiatric Consultant training expectations Overview of upcoming CMTS training
More informationTake a Course of Action.
Take a Course of Action. When you choose RAPS Online University, you ll be on track to expand your regulatory knowledge and advance your career. Our comprehensive learning provides an immersive experience
More informationTraining & Resources for Clinical Research Professionals
a division of Cambridge Healthtech Institute Training & Resources for Clinical Research Professionals Course & Publications Catalog January July 2013 In-Person and Web-Based Training Courses, Customized
More informationPhysician / Investigator. Over 40% of clinical trial data are entered into health record and EDC 1
EHR4CR AN INNOVATIVE PLATFORM AND BUSINESS MODEL ACDM Annual Conference, 9 Richard Perkins, eclinical Forum Electronic Health Records for Clinical Research 1 Industry-centric growth in ICT 57% of R&D investment
More informationJohn R. Kasich, Governor Tracy J. Plouck, Director
John R. Kasich, Governor Tracy J. Plouck, Director All Ohio March 24, 2017 Ohio Medicaid Behavioral Health Redesign Initiative The Redesign Initiative is an integral component of Ohio s comprehensive strategy
More informationPotential of the use of electronic patient information for clinical research in the pharmaceutical industry
Potential of the use of electronic patient information for clinical research in the pharmaceutical industry The case of the EHR4CR project Mats Sundgren, AstraZeneca Coordinator 1 Outline Problem statement
More informationPharmacopoeia Conference
PDA Europe Conference, Exhibition, Education The Parenteral Drug Association presents: Pharmacopoeia Conference Convergence, Harmonization & The Future Direction of Pharmacopoeias EXHIBITION & SPONSORSHIP
More informationThe Journey to Meaningful Use: Where we were, where we are, and where we may be going
The Journey to Meaningful Use: Where we were, where we are, and where we may be going June 27, 2013 Matthew Stanford, WHA Louis Wenzlow, RWHC 1 Where have we been? When HIT Adop on Meaningful Use Adoption
More informationA National Role Delineation Study of the Pediatric Emergency Nurse. Executive Summary
A National Role Delineation Study of the Pediatric Emergency Nurse Executive Summary Conducted for the Board of Certification for Emergency Nursing Prepared by Lawrence J. Fabrey, PhD, Sr. Vice President,
More informationHybrid Hyperbaric Introductory Course
Hybrid Hyperbaric Introductory Course Hyperbaric Medicine Principles & Practice 40 Hour On-Line Didactic Lectures On-Site Hands-on Practicum 6737 W. Washington St., #3265 West Allis, WI 53214 p. 414.269.5337
More informationSponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law
EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK
More informationFebruary 4, John-Paul M. Mario, ASID Affiliate Chair 2011-Present Dear Affiliates:
February 4, 2014 Dear Affiliates: John-Paul M. Mario, ASID Affiliate Chair 2011-Present JohnPaulASID@gmail.com 941-228-9968 As we begin this new year I and the Affiliate Advisory Board are looking forward
More informationProduce Safety Educator s Monthly Call #16 April 6, PM EST Meeting Summary
Produce Safety Educator s Monthly Call #16 April 6, 2015 2 PM EST Meeting Summary Total Attendance: 42 Meeting recording available at: https://cornell.webex.com/cornell/lsr.php?rcid=50401409f7d739b4642d051833685f3a
More informationBeyond Cost and Utilization: Rethinking Evaluation Strategies for Complex Care Programs
Beyond Cost and Utilization: Rethinking Evaluation Strategies for Complex Care Programs April 9, 2-3:30 pm (ET) Made possible with support from Kaiser Permanente Community Health Housekeeping This event
More information36 th Annual Meeting Preconference Workshop P4 Handout
36 th Annual Meeting Preconference Workshop P4 Handout Clinical Trial Management in Multicenter Trials: Collaborating for Success Meet Our Team Dixie Ecklund, RN, MSN, MBA Associate Director, University
More informationRegistries for Evaluating Patient Outcomes:
Registries for Evaluating Patient Outcomes: An Introduction to the User s Guide Michelle B. Leavy Managing Editor December 17, 2013 Copyright 2013 Quintiles Your Presenter Michelle Leavy, MPH Research
More informationAN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES
1 AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES Key Clinical Study Tasks and Activities 2 Discussion of Key Tasks and Activities 3 Development of the Clinical Protocol and Study Materials 3 Qualification
More informationVCU Clinical Research Quality Assurance Assessment
VCU Clinical Research Quality Assurance Assessment Principal Investigator Protocol Title Protocol IRB Number Name of Person Completing Assessment Date Assessment was Completed The goal of this assessment
More informationDetermining and Reporting Adverse Events vs. Product Complaints
Determining and Reporting Adverse Events vs. Product Complaints Pharma Perspective: Jacqueline Grissinger Director, Office of Consumer Medical Safety Johnson & Johnson Medical Device Perspective: Lisa
More informationInternational Perspectives. Marjorie S. Greenberg, MA National Center for Health Statistics Centers for Disease Control and Prevention
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationVascular Surgery Academic Coordinating Center (VSACC) & Peripheral Vascular Core Lab (PVCL)
Vascular Surgery Academic Coordinating Center (VSACC) & Peripheral Vascular Core Lab (PVCL) What are the VSACC and the PVCL? The Vascular Surgery Academic Coordinating Center (VSACC) is an academic research
More informationIntertek Health, Environmental & Regulatory Services
Intertek Health, Environmental & Regulatory Services Vai dove Ti porta la Chimica Go where the markets for Chemicals are! Workshop Centro REACH - 3 rd December 2014 Turkey - a country moving towards Europe
More informationCMS Priorities, MACRA and The Quality Payment Program
CMS Priorities, MACRA and The Quality Payment Program Ashby Wolfe, MD, MPP, MPH Chief Medical Officer, Region IX Centers for Medicare and Medicaid Services Presentation on behalf of HSAG November 16, 2016
More informationEUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)
EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) 31 January 2013 1 EUCERD RECOMMENDATIONS ON RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) INTRODUCTION 1. BACKGROUND TO
More informationGuideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol
1 2 31 January 2017 EMA/430909/2016 3 4 5 Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or Draft Adopted by GCP Inspectors Working Group (GCP IWG) 30 January 2017 Adopted
More information2016 Nominating Committee. ICANN55 9 March 2016
2016 Nominating Committee ICANN55 9 March 2016 Agenda 1 2 3 Introduction Stéphane Van Gelder Chair, 2016 NomCom Key Leadership Positions to be filled How to APPLY 4 5 6 NomCom Selection Process and Timeline
More informationNEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES
NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM-003 SOP category: Trial Management Version number: 04 Version date:
More informationCurrent and future standardization issues in the e Health domain: Achieving interoperability. Executive Summary
Report from the CEN/ISSS e Health Standardization Focus Group Current and future standardization issues in the e Health domain: Achieving interoperability Executive Summary Final version 2005 03 01 This
More informationJAS WG Final Report Supporting Applicants from Developing Economies. September 2011 Presenters: Avri Doria; Alan Greenberg
JAS WG Final Report Supporting Applicants from Developing Economies September 2011 Presenters: Avri Doria; Alan Greenberg Agenda Terminology Clarification Why provide support? Activities timeline Final
More informationDelivering a quality CDISC compliant accelerated submission using an outsourced model Mei Dey, AstraZeneca (USA) Diane Peers, AstraZeneca (UK)
PharmaSUG 2016 - Paper PO11 Delivering a quality CDISC compliant accelerated submission using an outsourced model Mei Dey, AstraZeneca (USA) Diane Peers, AstraZeneca (UK) ABSTRACT Pharmaceutical companies
More informationThis is a full time post offered on a fixed-term basis until 31 August 2019.
Faculty of Medicine and Health Sciences Norwich Medical School CTU Trial Assistant REF: SC3019 This is a full time post offered on a fixed-term basis until 31 August 2019. The Post A Clinical Trial Assistant
More informationInvestigator Initiated-Sponsored Research (IISR)
Investigator Initiated-Sponsored Research (IISR) State of the Industry and the Need for Global Standards and Metrics Alexander Kostek and DeeAnn Tinjum Disclaimer The views and opinions expressed by the
More information22 Days til MIPS Data Submission! Get Ready!
Countdown to MIPS* Data Submission Webinar Series 22 Days til MIPS Data Submission! Get Ready! Christine Lalios Kuykendall, BS, RHIA, CPHQ, IM Health Informatics Specialist Health Services Advisory Group
More informationFINAL DOCUMENT. Global Harmonization Task Force
GHTF/SG5/N5:2012 FINAL DOCUMENT Global Harmonization Task Force Title: Reportable Events During Pre-Market Clinical Investigations Authoring Group: Study Group 5 of the Global Harmonization Task Force
More informationStandard Operating Procedures
Clinical Monitoring and Site Verification Procedure Overview To define the standard procedures for preparation and documentation of site visits for clinical monitoring and spoke verification for any NETT
More informationDirect Patient ADR reporting system in Japan. Kazuhiko Mori, Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Direct Patient ADR reporting system in Japan Kazuhiko Mori, Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA), Japan Disclaimer The views and opinions expressed in the following PowerPoint
More informationThe Pain or the Gain?
The Pain or the Gain? Comprehensive Care Joint Replacement (CJR) Model DRG 469 (Major joint replacement with major complications) DRG 470 (Major joint without major complications or comorbidities) Actual
More informationInternational District Cooling & Heating Conference
International District Cooling & Heating Conference Consumer tariffs and markets Accelerating Urban Energy Systems in the Asia Pacific Region Mikael Jakobsson Executive Director Asia Pacific Urban Energy
More informationEssential Documents It s Not Just a Binder!
Essential Documents It s Not Just a Binder! Kelly Unsworth, MS, CCRC, CIP Director of Research Education & Training Office for Human Subject Protection SCORE June 5, 2014 But What percentage of 2014 (to
More informationPHMPapers.org The PHM Society s paper submission, review, and distribution portal Conference Submission Instructions for Authors
PHMPapers.org The PHM Society s paper submission, review, and distribution portal Conference Submission Instructions for Authors 1 Introduction Welcome to PHMPapers.org! The PHM Society is now using a
More informationCOMMISSIONING SUPPORT PROGRAMME. Standard operating procedure
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the
More informationComparative Effectiveness Research and Patient Centered Outcomes Research in Public Health Settings: Design, Analysis, and Funding Considerations
University of Kentucky UKnowledge Health Management and Policy Presentations Health Management and Policy 12-7-2012 Comparative Effectiveness Research and Patient Centered Outcomes Research in Public Health
More informationDelivery time frame for the EU portal and EU database
17 December 2015 EMA/760345/2015 Endorsed Draft time frame presented to European Medicines Agency Management Board 01 October 2015 Draft timeframe presented to IT Directors and Member States during the
More informationPOSTGRADUATE DIPLOMA/MSc IN PHARMACEUTICAL MEDICINE
POSTGRADUATE DIPLOMA/MSc IN PHARMACEUTICAL MEDICINE 2018/2020 University of Dublin, Trinity College Index Introduction... 1 Aims... 1 Intended Participants... 1 Course Structure... 2 Course Content and
More informationEuropean CRO Federation
European CRO Federation The interface between Industry CRO and Clinical Trials Networks: Defining the Roles EMA, London, 22 March 2012 Dr. Martine Dehlinger-Kremer Vice President Global Regulatory Affairs,
More informationMIPS Advancing Care Information: Tips, Tools and Support Q&A from Live Webinar March 29, 2017
MIPS Advancing Care Information: Tips, Tools and Support Q&A from Live Webinar March 29, 2017 Below are questions that were submitted during the Quality Insights Advancing Care Information webinar on March
More informationWork plan for GCP Inspectors Working Group for 2018
22 March 2018 EMA/87812 /2018 Committees and Inspections Chairperson: Ana Rodriguez The activities outlined in the work plan for 2018 have been agreed in view of preparation for the Agency s relocation
More informationJune OLTL Updates PANAC June Agenda. RAI Spotlight PENNSYLVANIA DEPARTMENT OF HUMAN SERVICES OFFICE OF LONG-TERM LIVING
PENNSYLVANIA DEPARTMENT OF HUMAN SERVICES OFFICE OF LONG-TERM LIVING OLTL Updates PANAC Ruth Anne Barnard, BSN, RN MDS/OBRA Coordinator for Nursing Facility Field Operations Catharine B. Petko, BSN, RN
More informationStandard Operating Procedure
Standard Operating Procedure SOP number: SOP full title: SOP-JRO-07-004 Recording, managing and reporting Adverse Events for Clinical Trials of Investigational Medicinal Products and trials of Advanced
More informationSPONSORSHIP PACKAGES ENERGY EFFICIENCY WATCH 3 PROJECT Status 09 December 2014
SPONSORSHIP PACKAGES ENERGY EFFICIENCY WATCH 3 PROJECT 2014-2017 Status 09 December 2014 EEW3 PROJECT DESCRIPTION... 1 WHO IS BEHIND THE PROJECT?... 2 BACKGROUND OF THE EEW3... 3 WHY SPONSOR?... 4 OVERVIEW
More informationSt. James s Hospital Research Governance and Support Framework
St. James s Hospital Research Governance and Support Framework 2017 2019 St. James s Hospital Research Governance & Support Framework 2017 2019 Table of Contents SECTION 1... 1 1.1 Introduction... 1 1.2
More informationInformation & Publicity of structural funds: The challenge of conforming to I&P rules and the importance of web based tools
Information & Publicity of structural funds: The challenge of conforming to I&P rules and the importance of web based tools Angelika IOANNIDES Head of Programming & Communication Management Organisation
More informationOneCity Health Partner Webinar
1 OneCity Health Partner Webinar Past, Present, and Looking Ahead December 13, 2016 Today s Presenter 2 Richard Bernstock, Bronx Hub Executive Director Topics for Today s Webinar 3 OneCity Health Partner
More information2018 Quality Award New Applicant Overview Webinar August 22 nd 2017
2018 Quality Award New Applicant Overview Webinar August 22 nd 2017 Urvi Patel, Director, Quality Improvement Erin Prendergast, MPH, Senior Manager, Quality Improvement What is the Quality Award Program?
More informationAWS SUMMITS LATAM 2016
AWS SUMMITS LATAM 2016 Bogota April 6, 2016 Corferias Buenos Aires April 28, 2016 Darwin Santiago May 3, 2016 W Hotel Mexico City May 26 th 2016 Centro Banamex Lima September 28 th 2016 The Westin Re-invent
More informationConformity Assessment Approaches and Best Practices NIST Public Workshop. Session 4: Conformity Assessment Case Study Personal Protective Technologies
Conformity Assessment Approaches and Best Practices NIST Public Workshop Session 4: Conformity Assessment Case Study Personal Protective Technologies Maryann D Alessandro, Ph.D. Director, National Personal
More informationEncounter Data System
System Industry February 2, 2012 1 Introduction Session Guidelines CMS Agenda o Testing Timeline o EDFES Certification Status Test Cases Review Reports o EDFES 277CA o EDPS MAO-002 Flat File and Formatted
More informationMAXIMUS Webinar Series
MAXIMUS Webinar Series What the Provider Enrollment Rule Means Operationally for States and MCOs, Including Network Adequacy Continuing the Discussion on the CMS Rule for Medicaid & CHIP Managed Care June
More informationExperiences of using routinely collected medical data in a cardiovascular safety trial?
Experiences of using routinely collected medical data in a cardiovascular safety trial? Ian Ford Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit Issues in clinical trials Study feasibility
More informationLatham & Watkins Corporate Department
Number 1133 January 27, 2011 Client Alert Latham & Watkins Corporate Department FDA Announces Actions Designed to Improve the 510(k) Premarket Clearance Process Importantly, however, the Agency s identified
More informationCo-operative Agreement for Research Ethics Review between NHG DSRB and NTU IRB
Co-operative Agreement for Research Ethics Review between NHG DSRB and NTU IRB Frequently Asked Questions 1. What type of collaborative studies is eligible for single IRB reviews? All new collaborative
More informationA Dedicated Post Authorisation Measure Submission Form
A Dedicated Post Authorisation Measure Submission Form An improved way of submitting your PAM to the EMA Presented by Hector Boix Perales on 03 July 2017 Procedure Management Department Human Medicines
More informationU.S. Chamber of Commerce 1615 H Street NW Washington, DC INTERNSHIP PROGAM
U.S. Chamber of Commerce 1615 H Street NW Washington, DC 20062 INTERNSHIP PROGAM Summer 2017 Internship Opportunities Communications Title: Communications & Strategy Intern Department Description: The
More informationIPRO ESRD Network of the South Atlantic HAI BSI/LTC QIA 2018 Kickoff Webinar
IPRO ESRD Network of the South Atlantic HAI BSI/LTC QIA 2018 Kickoff Webinar February 7, 2018 Welcome/Opening Remarks Jeanine Pilgrim, Quality Improvement Director Housekeeping Reminders All phone lines
More informationCDISC 2012 Annual Report TEAMWORK.... with collaboration there is strength.
CDISC 2012 Annual Report TEAMWORK... with collaboration there is strength. President s Letter Unity is strength when there is teamwork and collaboration, wonderful things can be achieved. Mattie Stepanek,
More informationMeasures of impact of pharmacovigilance processes (3.3)
Measures of impact of pharmacovigilance processes (3.3) Session 4 - Reports from breakout sessions: gaps and observations Workshop: Measuring the Impact of Pharmacovigilance Activities London, 5-6 December
More information